By staff writers

October 17, 2012 -- Radiopharmaceutical firm Jubilant DraxImage has named Dr. Norman LaFrance as vice president, medical and regulatory affairs, and chief medical officer (CMO).

LaFrance comes to Jubilant DraxImage after stints at DuPont Merck, Bracco, Celltech, Bausch & Lomb, and Molecular Insight Pharmaceuticals. He is also the industry's representative to the U.S. Food and Drug Administration's Medical Imaging Drugs Advisory Committee (MIDAC).

In addition, LaFrance retains active medical licensure and is double board-certified in both nuclear medicine and internal medicine, Jubilant DraxImage said.

Copyright © 2012

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking